Pozen Wins Injunction On Generic Treximet
A Texas federal judge ruled Friday that Par Pharmaceutical Cos. Inc. and two other drugmakers had infringed Pozen Inc.'s patents covering the migraine treatment Treximet and barred them from selling generic...To view the full article, register now.
Already a subscriber? Click here to view full article